The Next Wave: Cell and Gene Therapy’s Commercial Shift

19 Jan 2023
Manufacturing Advanced Therapies Track
Charles River

15:30pm Chair Introduction

Matthew Hewitt, Executive Director Scientific Services, Cell and Gene Therapy, Charles River Laboratories


15:35am Presentation: Pioneering a New Wave of Gene-Agnostic Gene Therapy

  • Recent advancements in gene therapy
  • Overview of retinal degenerative disease
  • Novel, gene-agnostic optogenetics approach to treat retinal degenerative disease
  • Clinical program overview and next steps

Samarendra Mohanty, Co-Founder and President, Nanoscope Therapeutics


16:05am Presentation:  Present and Future of Cell and Gene Therapies

  • Overview of cell therapy progress to date
  • Critical technological advancements driving robust development, manufacturing and testing
  • Leveraging a discovery platform to engineer a TCR-T cell therapy product to treat AML
  • Future direction of the cell therapy industry

Robert Keefe, Chief Development Officer, BlueSphere


16:35pm Closing Panel with Q&A

With all session participants


Matthew Hewitt
Executive Director, Scientific Services, Cell and Gene Therapy
Charles River
Robert Keefe
Chief Development Officer
BlueSphere Bio
Samarendra Mohanty
Co-Founder and President
Nanoscope Therapeutics